JOHN L. HIGGINS - 30 Oct 2025 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for John L. Higgins pursuant to Power of Attorney previously filed
Issuer symbol
TECH
Transactions as of
30 Oct 2025
Transactions value $
$0
Form type
4
Filing time
03 Nov 2025, 17:25:52 UTC
Previous filing
11 Aug 2025
Next filing
10 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HIGGINS JOHN L Director 614 MCKINLEY PLACE NE, MINNEAPOLIS /s/ Andrew Nick as Attorney-in-Fact for John L. Higgins pursuant to Power of Attorney previously filed 03 Nov 2025 0001208906

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Award $0 +1.64K +2.51% $0.00 66.9K 30 Oct 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Award $0 +3.78K $0.00 3.78K 30 Oct 2025 Common Stock 3.78K $60.96 Direct F1
holding TECH Stock Options (Right to Buy) 15.9K 30 Oct 2025 Common Stock 15.9K $25.30 Direct
holding TECH Stock Options (Right to Buy) 12.5K 30 Oct 2025 Common Stock 12.5K $31.26 Direct
holding TECH Stock Options (Right to Buy) 7.59K 30 Oct 2025 Common Stock 7.59K $44.96 Direct
holding TECH Stock Options (Right to Buy) 8.04K 30 Oct 2025 Common Stock 8.04K $50.41 Direct
holding TECH Stock Options (Right to Buy) 6.03K 30 Oct 2025 Common Stock 6.03K $63.92 Direct
holding TECH Stock Options (Right to Buy) 2.53K 30 Oct 2025 Common Stock 2.53K $128.81 Direct
holding TECH Stock Options (Right to Buy) 3.46K 30 Oct 2025 Common Stock 3.46K $73.94 Direct
holding TECH Stock Options (Right to Buy) 3.94K 30 Oct 2025 Common Stock 3.94K $61.51 Direct
holding TECH Stock Options (Right to Buy) 3.51K 30 Oct 2025 Common Stock 3.51K $68.37 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.